In vivo evolution of a novel, syncytium-inducing and cytopathic feline leukemia virus variant

Journal of Virology

Volumn 72, Issue 4, 1998, Pages 2686-2696

  Rohn, Jennifer L ^a   Moser, Maria S ^a   Gwynn, Samuel R ^a   Baldwin, David N ^a   Overbaugh, Julie ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ARTICLE; CAT; CELL KILLING; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; ENVELOPE GENE; EVOLUTION; FELINE LEUKEMIA VIRUS; IMMUNE DEFICIENCY; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYNCYTIUM; T LYMPHOCYTE; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS TRANSMISSION; VIRUS TYPING;

EID: 0031925582     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.4.2686-2696.1998     Document Type: Article

References (47)

1. Anderson, K. B., and H. Skov. 1989. Retrovirus-induced cell fusion is enhanced by protease treatment. J. Gen. Virol. 70:1921-1927.
2. Aronoff, R., and M. Linial. 1991. Specificity of retroviral RNA packaging. J. Virol. 65:71-80.
3. Asjo, B., L. Morfeldt-Manson, J. Albert, G. Biberfeld, A. Karlsson, K. Lidman, and E. M. Fenyo. 1986. Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection. Lancet 2:660-662.
4. Boomer, S., M. Eiden, C. C. Burns, and J. Overbaugh. 1997. Three distinct envelope domains, variably present in subgroup B feline leukemia virus recombinants, mediate Pit1 and Pit2 receptor interactions. J. Virol. 71:8116-8123.
5. Burns, C., M. Moser, J. Banks, J. Alderete, and J. Overbaugh. 1996. Identification and deletion of sequences required for feline leukemia virus RNA packaging and construction of a high-titer feline leukemia virus packaging cell line. Virology 222:14-20.
6. Burns, C. C., M. L. Poss, E. Thomas, and J. Overbaugh. 1995. Mutations within a putative cysteine loop of the transmembrane protein of an attenuated immunodeficiency-inducing feline leukemia virus variant inhibit envelope protein processing. J. Virol. 69:2126-2132.
7. Cheng-Mayer, C., D. Seto, M. Tateno, and J. A. Levy. 1988. Biologic features of HIV-1 that correlate with virulence in the host. Science 240:80-82.
8. De Noronha, C. M., T. A. Reinhart, and J. I. Mullins. 1996. Generation and role of defective proviruses in cytopathic feline leukemia virus (FeLV-FAIDS) infections. J. Virol. 70:359-367.
9. Donahue, P. R., E. A. Hoover, G. A. Beltz, N. Riedel, V. M. Hirsch, J. Overbaugh, and J. I. Mullins. 1988. Strong sequence conservation among horizontally transmissible, minimally pathogenic feline leukemia viruses. J. Virol. 62:722-731.
10. Donahue, P. R., S. L. Quackenbush, M. V. Gallo, C. M. C. deNoronha, J. Overbaugh, E. A. Hoover, and J. I. Mullins. 1991. Viral genetic determinants of T-cell killing and immunodeficiency disease induction by the feline leukemia virus FeLV-FAIDS. J. Virol. 65:4461-4469.
11. Feichtinger, H., E. Kaaya, P. Putkonen, S. L. Li, and M. Ekman. 1992. Malignant lymphoma associated with human AIDS and with SIV-induced immunodeficiency in macaques. AIDS Res. Hum. Retroviruses 8:339-348.
12. Fenyö, E. M., L. Morfeldt-Manson, F. Chiodi, B. Lind, A. von Gegerfelt, J. Albert, E. Olausson, and B. Asjö. 1988. Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates. J. Virol. 62:4414-4419.
13. Fields-Berry, S. C., A. L. Halliday, and C. L. Cepko. 1992. A recombinant retrovirus encoding alkaline phosphatase confirms clonal boundary assignment in lineage analysis of murine retina. Proc. Natl. Acad. Sci. USA 89: 693-697.
14. Goff, S., P. Traktman, and D. Baltimore. 1981. Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase. J. Virol. 38:239-248.
15. Grant, C. K., B. J. Ernisse, O. Jarrett, and F. R. Jones. 1983. Feline leukemia virus envelope gp70 of subgroups B and C defined by monoclonal antibodies with cytotoxic and neutralizing functions. J. Immunol. 131:3042-3048.
16. Gurley, R. J. 1990. The clinical spectrum of HIV infection, p. 359-381. In R. C. Gallo and F. Wong-Staal (ed.), Retrovirus biology and human disease. Academic Press, San Diego, Calif.
17. Hardy, W. D. 1993. Feline oncoretroviruses, p. 109-180. In J. A. Levy (ed.), The Retroviridae, vol. 2. Plenum Press. New York, N.Y.
18. Hoover, E. A., J. I. Mullins, S. L. Quackenbush, and P. W. Gasper. 1987. Experimental transmission and pathogenesis of immunodeficiency syndrome in cats. Blood 70:1880-1892.
19. Kristal, B. S., T. A. Reinhart, E. A. Hoover, and J. I. Mullins. 1993. Interference with superinfection and with cell killing and determination of host range and growth kinetics mediated by feline leukemia virus surface glycoproteins. J. Virol. 67:4142-4153.
20. Levy, L. S., P. A. Lobelle-Rich, and J. Overbaugh. 1993. flvi-2, a target of retroviral insertional mutagenesis in feline thymic lymphosarcomas, encodes bmi-1. Oncogene 8:1833-1838.
21. Levy, L. S., P. A. Lobelle-Rich, J. Overbaugh, J. L. Abkowitz, R. Fulton, and P. Roy-Burman. 1993. Coincident involvement of flvi-2, c-myc, and novel env genes in natural and experimental lymphosarcomas induced by feline leukemia virus. Virology 196:892-895.
22. Miller, A. D., J. V. Garcia, S. N. von, C. M. Lynch, C. Wilson, and M. V. Eiden. 1991. Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus. J. Virol. 65:2220-2224.
23. Miller, D. G., R. H. Edwards, and A. D. Miller. 1994. Cloning of the cellular receptor for amphotropic murine retroviruses reveals homology to that for gibbon ape leukemia virus. Proc. Natl. Acad. Sci. USA 91:78-82.
24. Moser, M., C. Burns, S. Boomer, and J. Overbaugh. The host range and interference properties of two closely related feline leukemia virus variants suggest that they use distinct receptors. Virology, in press.
25. Mullins, J. I., C. S. Chen, and E. A. Hoover. 1986. Disease-specific and tissue-specific production of unintegrated feline leukaemia virus variant DNA in feline AIDS. Nature 319:333-336.
26. Mullins, J. I., E. A. Hoover, S. L. Quackenbush, and P. R. Donahue. 1991. Disease progression and viral genome variants in experimental feline leukemia virus-induced immunodeficiency syndrome. J. Acquired Immune Defic. Syndr. 4:547-557.
27. Overbaugh, J., P. R. Donahue, S. L. Quackenbush, E. A. Hoover, and J. I. Mullins. 1988. Molecular cloning of a feline leukemia virus that induces fatal immunodeficiency disease in cats. Science 239:906-910.
28. Overbaugh, J., E. A. Hoover, J. I. Mullins, D. P. W. Burns, L. Rudensey, S. L. Quackenbush, V. Stallard, and P. R. Donahue. 1992. Structure and pathogenicity of individual variants within an immunodeficiency disease-inducing isolate of FeLV. Virology 188:558-569.
29. Overbaugh, J., and L. M. Rudensey. 1992. Alterations in potential sites for glycosylation predominate during evolution of the simian immunodeficiency virus envelope gene in macaques. J. Virol. 66:5937-5948.
30. Park, B. H., E. Lavi, K. J. Blank, and G. N. Gaulton. 1993. Intracerebral hemorrhages and syncytium formation induced by endothelial cell infection with a murine leukemia virus. J. Virol. 67:6015-6024.
31. Pinter, A., T.-E. Chen, A. Lowey, N. G. Cortez, and S. Silagi. 1986. Ecotropic murine leukemia virus-induced fusion of murine cells. J. Virol. 57:1048-1054.
32. Quackenbush, S. L., P. R. Donahue, G. A. Dean, M. H. Myles, C. D. Ackley, M. D. Cooper, J. I. Mullins, and E. A. Hoover. 1990. Lymphocyte subset alterations and viral determinants of immunodeficiency disease induction by the feline leukemia virus FeLV-FAIDS. J. Virol. 64:5465-5474.
33. Reinhart, T. A., A. K. Ghosh, E. A. Hoover, and J. I. Mullins. 1993. Distinct superinfection interference properties yet similar receptor utilization by cytopathic and noncytopathic feline leukemia viruses. J. Virol. 67:5153-5162.
34. Rohn, J., A. Lauring, M. Linenberger, and J. Overbaugh. 1996. Transduction of Notch2 in feline leukemia virus-induced thymic lymphoma. J. Virol. 70: 8071-8080.
35. Rohn, J. L., M. L. Linenberger, E. A. Hoover, and J. Overbaugh. 1994. Evolution of feline leukemia virus variant genomes with insertions, deletions, and defective envelope genes in infected cats with tumors. J. Virol. 68:2458-2467.
36. Rohn, J. L., and J. Overbaugh. 1997. Pathogenic feline retroviruses: feline leukemia virus and feline immunodeficiency virus. In I. S. Y. Chen and R. Ahmed (ed.), persistent viral infections, in press. John Wiley & Sons, Inc., New York, N.Y.
37. Rowe, W. P., W. E. Pugh, and J. W. Hartley. 1970. Plaque assay techniques for murine leukemia viruses. Virology 42:1136-1139.
38. Rudensey, L. M., J. T. Kimato, R. E. Benveniste, and J. Overbaugh. 1995. Progression to AIDS in macaques is associated with changes in the replication, tropism, and cytopathic properties of the simian immunodeficiency virus variant population. Virology 207:528-542.
39. Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5467.
40. Temin, H. M. 1988. Mechanisms of cell killing/cytopathic effects by nonhuman retroviruses. Rev. Infect. Dis. 10:399-405.
41. Tersmette, M., R. E. Y. de Goede, B. J. M. Al, I. N. Winkel, R. A. Gruters, H. T. Cuypers, H. G. Huisman, and F. Miedema. 1988. Differential syncytium-inducing capacity of human immunodeficiency virus isolate: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. J. Virol. 62:2026-2032.
42. Tersmette, M., R. A. Gruters, F. de Wolf, R. E. Y. de Goede, J. M. A. Lange, P. T. A. Schellekens, J. Goudsmit, H. G. Huisman, and F. Miedema. 1989. Evidence for a role of virulent human immunodeficiency virus (HIV) in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates. J. Virol. 63:2118-2125.
43. Tersmette, M., J. M. Lange, R. E. de Goede, F. de Wolf, J. K. Eeftink-Schattenkerk, P. T. Schellekens, R. A. Coutinho, J. G. Huisman, J. Goudsmit, and F. Miedema. 1989. Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality. Lancet 1:983-985.
44. Thomas, E., and J. Overbaugh. 1993. Delayed cytopathicity of a feline leukemia virus variant is due to four mutations in the transmembrane protein gene. J. Virol. 67:5724-5732.
45. White, J. 1992. Membrane fusion. Science 258:917-924.
46. Wilson, C. A., J. W. Marsh, and M. V. Eiden. 1992. The requirements for viral entry differ from those for virally induced syncytium formation in NIH 3T3/DTras cells exposed to Moloney murine leukemia virus. J. Virol. 66: 7262-7269.
47. Wong, P. K. Y., P. H. Yuen, and S. J. Kaufman. 1977. Induction of syncytia by Moloney murine leukemia virus in myoblasts defective in differentiation. J. Virol. 21:319-327.